TIPARP and cancer: To better understand the effect of Parp7 loss on T cell tumour infiltration, we also used a dedicated spectral flow cytometry panel capable of differentiating cancer-relevant T cell subpopulations including cytotoxic (CD8), helper (CD4), and TCRγδ T cells (Figures 6A–C; Supplementary Figure S6).